Mark C. Wiggins, EVP Corporate and Business Development at BIOGEN IDEC INC. (BIIB), sold 89,645 shares at $82.00 ($7.4M) on 2007-10-15, disclosed to the SEC on 2007-10-17.
Scheduled sale ($7.4M) by EVP Corporate and Business Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ZGNX | BUY | 2020-03-24 | $51K | — | Filing → |
| TCON | BUY | 2020-01-24 | $20K | — | Filing → |
| ZGNX | SELL | 2019-08-12 | $313K | — | Filing → |